Effects of potassium aspartate and magnesium on ventricular arrhythmia in ischemia-reperfusion rabbit heart

Abstract

The aim of this study was to determine if the potassium aspartate and magnesium (PAM) prevent reperfusion-induced ventricular arrhythmias (RIVA) in ischemia-reperfusion (IR) rabbit heart. Thirty rabbits were randomly divided into control, ischemia and PAM groups. Arterially-perfused rabbit left ventricular preparations were made, and transmural ECG as well as action potentials from both endocardium and epicardium were simultaneously recorded in the whole process of all experiments. In control group rabbit ventricular wedge preparations were continuously perfused with Tyrode’s solution, and in ischemia group and PAM groups the perfusion of Tyrode’s solution was stopped for 30 min. Then the ischemia group was reperfused with Tyrode’s solution and the PAM group with Tyrode’s solution containing 2.42 mg/L PAM, respectively. ECG, QT interval, transmural repolarization dispersion (TDR) and action potentials from epicardium and endocardium were simultaneously recorded, and the RIVA of the wedge preparation was observed. Compared with control group, TDR and incidence of RIVA were significantly increased in ischemia group (P<0.05). The incidence of RIVA in control, ischemia and PAM group was 0/10, 9/10 and 1/10, respectively. Compared with ischemia group, TDR and incidence of RIVA were significantly reduced in PAM group (P<0.05). Potassium aspartate and magnesium significantly reduce TDR and prevent ventricular arrhythmia in ischemic rabbit heart.

Keywords

ischemia-reperfusion / ventricular arrhythmia / potassium aspartate and magnesium

References

[1] BayesD. L., CoumelP., LeclercqJ. F.. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J, 1989, 117(1): 151-159

[2] YanG. X., JoshiA., GuoD., et al.. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation, 2004, 110(9): 1036-1041

[3] WangX. G., GaoX. W., ZenQ. T.. Effects of magnesium sulfateon on ventricular arrhythmias in patients with chronic congestive heart failure. J Clin Cardiol (Chinese), 2001, 17(6): 276-277

[4] QuanX. Q., BaiR., LiuN., et al.. Increasing gap junction coupling reduces transmural dispersion of repolarization and prevents torsade de pointes in rabbit LQT3 model. J Cardiovasc Electrophysiol, 2007, 18(11): 1184-1189

[5] HaigneyM. C., MiyataH., LakattaE. G., et al.. Dependence of hypoxic cellular calcium loading on Na⁺Ca²⁺ exchange. Cir Res, 1992, 71(3): 547-557

[6] CairnsJ. A., ConnollyS. J., RobertsR., et al.. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Canadian Amiodarone Myocardial Infarction Trial Investigators. Lancet, 1997, 349(9053): 675-682

[7] EchtD. S., LiebsonP. R., MitchellL. B., et al.. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med, 1991, 324(12): 781-788

[8] ZhengH., LinY. G., LiY. F., et al.. The application of potassium aspartate and magnesium in heart operation. Chin Cardiovascular J (Chinese), 1996, 24(1): 31-32

[9] WuJ., ZipesD. P.. Early afterdepolarizations, U waves, and Torsades de Pointes. Circulation, 2002, 105(6): 675-676